Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Prepaid Assets (2016 - 2025)

Corcept Therapeutics (CORT) has disclosed Prepaid Assets for 14 consecutive years, with $7.1 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 16.85% to $7.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.1 million through Dec 2025, up 16.85% year-over-year, with the annual reading at $7.1 million for FY2025, 16.85% up from the prior year.
  • Prepaid Assets hit $7.1 million in Q4 2025 for Corcept Therapeutics, down from $37.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $39.6 million in Q1 2025 to a low of $4.6 million in Q3 2024.
  • Historically, Prepaid Assets has averaged $16.3 million across 5 years, with a median of $15.6 million in 2022.
  • Biggest five-year swings in Prepaid Assets: crashed 77.95% in 2024 and later skyrocketed 718.1% in 2025.
  • Year by year, Prepaid Assets stood at $10.3 million in 2021, then surged by 59.22% to $16.4 million in 2022, then soared by 67.82% to $27.6 million in 2023, then plummeted by 77.95% to $6.1 million in 2024, then increased by 16.85% to $7.1 million in 2025.
  • Business Quant data shows Prepaid Assets for CORT at $7.1 million in Q4 2025, $37.5 million in Q3 2025, and $7.5 million in Q2 2025.